Leukemia Journal Issues Research Articles in September 2022 Edition
August 27, 2022
August 27, 2022
LONDON, England, Aug. 27 -- Leukemia, a journal that says it covers research and treatment of leukemia and allied diseases, published research articles on the following topics in its September 2022 edition:
Articles:
* Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome
* GFI1B acts as a metabolic regulator in hematopoiesis and acute myelo . . .
Articles:
* Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome
* GFI1B acts as a metabolic regulator in hematopoiesis and acute myelo . . .